{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:33:07Z","timestamp":1771003987434,"version":"3.50.1"},"publisher-location":"Boston, MA","reference-count":141,"publisher":"Springer US","isbn-type":[{"value":"9781461363491","type":"print"},{"value":"9781461530886","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-1-4615-3088-6_8","type":"book-chapter","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T12:44:30Z","timestamp":1319201070000},"page":"167-192","source":"Crossref","is-referenced-by-count":7,"title":["Malignant transformation by abl and BCR\/ABL"],"prefix":"10.1007","author":[{"given":"Richard A.","family":"Van Etten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","doi-asserted-by":"crossref","unstructured":"Rosenberg N, Witte ON: The viral and cellular forms of the abelson (abl) oncogene. In: Advances in Virus Research. Academic Press, 1988, pp 39\u201381.","DOI":"10.1016\/S0065-3527(08)60708-3"},{"key":"8_CR2","first-page":"2213","volume":"30","author":"HT Abelson","year":"1970","unstructured":"Abelson HT, Rabstein LS: Lymphosarcoma: Virus-induced thymic-independent disease in mice. Cancer Res 30:2213\u20132222, 1970.","journal-title":"Cancer Res"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/253729a0","volume":"253","author":"CD Scher","year":"1975","unstructured":"Scher CD, Siegler R: Direct transformation of 3T3 cells by Abelson murine leukemia virus. Nature 253:729\u2013731, 1975.","journal-title":"Nature"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1073\/pnas.84.16.5932","volume":"84","author":"PL Green","year":"1987","unstructured":"Green PL, Kaehler DA, Risser R: Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus. Proc Natl Acad Sci USA 84:5932\u20135936, 1987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1084\/jem.148.3.714","volume":"148","author":"R Risser","year":"1978","unstructured":"Risser R, Potter M, Rowe WP: Abelson virus-induced lymphomagenesis in mice. J Exp Med 148:714\u2013726, 1978.","journal-title":"J Exp Med"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/MCB.9.6.2665","volume":"9","author":"GF Tidmarsh","year":"1989","unstructured":"Tidmarsh GF, Heimfeld S, Whitlock CA, Weissman IL, Muller-Sieburg CE: Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for abelson leukemia virus targets. Mol Cell Biol 9:2665\u20132671, 1989.","journal-title":"Mol Cell Biol"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(81)90421-9","volume":"27","author":"F Alt","year":"1981","unstructured":"Alt F, Rosenberg N, Lewis S, Thomas E, Baltimore D: Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: Rearrangement of heavy but not light chain genes. Cell 27:381\u2013390, 1981.","journal-title":"Cell"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.72.5.1932","volume":"72","author":"N Rosenberg","year":"1975","unstructured":"Rosenberg N, Baltimore D, Scher CD: In vitro transformation of lymphoid cells by abelson murine leukemia virus. Proc Natl Acad Sci USA 72:1932\u20131936, 1975.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR9","doi-asserted-by":"crossref","unstructured":"Potter M, Sklar MD, Rowe WP: Rapid viral induction of plasmacytomas in pristane-primed BALB\/c mice. Science 182:592\u2013594.","DOI":"10.1126\/science.182.4112.592"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","volume":"15","author":"WC Raschke","year":"1973","unstructured":"Raschke WC, Baird S, Ralph P, Nakoinz I: Functional macrophage cell lines transformed by abelson leukemia virus. Cell 15:261\u2013267, 1973.","journal-title":"Cell"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(85)80049-0","volume":"41","author":"JH Pierce","year":"1985","unstructured":"Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN: Neoplastic transformation of mast cells by abelson-MuLV: Abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685\u2013693, 1985.","journal-title":"Cell"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1073\/pnas.79.9.2917","volume":"79","author":"WD Cook","year":"1982","unstructured":"Cook WD: Rapid thymomas induced by Abelson murine leukemia virus. Proc Natl Acad Sci USA 79:2917\u20132921, 1982.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(81)90035-0","volume":"26","author":"GL Waneck","year":"1981","unstructured":"Waneck GL, Rosenberg N: Abelson leukemia virus induces lymphoid and erythroid colonies in infected fetal cell cultures. Cell 26:79\u201389, 1981.","journal-title":"Cell"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood.V71.4.973.973","volume":"71","author":"S-W Chung","year":"1988","unstructured":"Chung S-W, Ruscetti S, Wong PMC: Formation of factor-independent hematopoietic multilineage colonies after abelson virus infection. Blood 71:973\u2013977, 1988.","journal-title":"Blood"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1128\/MCB.7.7.2631","volume":"7","author":"WD Cook","year":"1987","unstructured":"Cook WD, De St. Groth BF, Miller JFAP, MacDonald HR, Gabathuler R: Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line. Mol Cell Biol 7:2631\u20132635, 1987.","journal-title":"Mol Cell Biol"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/MCB.6.11.4133","volume":"6","author":"B Mathey-Prevot","year":"1986","unstructured":"Mathey-Prevot B, Nabel G, Palacios R, Baltimore D: Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol Cell Biol 6:4133\u20134135, 1986.","journal-title":"Mol Cell Biol"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0092-8674(85)80048-9","volume":"41","author":"WD Cook","year":"1985","unstructured":"Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F: Malignant transformation of a growth factor-dependent myeloid cell line by abelson virus without evidence of an autocrine mechanism. Cell 41:677\u2013683, 1985.","journal-title":"Cell"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0092-8674(79)90208-3","volume":"18","author":"A Shields","year":"1979","unstructured":"Shields A, Goff S, Paskind M, Otto G, Baltimore D: Structure of the abelson murine leukemia virus genome. Cell 18:955\u2013962, 1979.","journal-title":"Cell"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1128\/JVI.32.3.1041-1045.1979","volume":"32","author":"WJ Ven van de","year":"1979","unstructured":"van de Ven WJ, Reynolds FH, Nalewaik RP, Stephenson JR: The nonstructural component of the Abelson murine leukemia virus polyprotein pl20 is encoded by newly acquired genetic sequences. J Virol 32:1041\u20131045, 1979.","journal-title":"J Virol"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/281396a0","volume":"5730","author":"ON Witte","year":"1979","unstructured":"Witte ON, Rosenberg NE, Baltimore D: A normal cell protein cross-reactive to the major abelson murine leukaemia virus gene product. Nature 5730:396\u2013398, 1979.","journal-title":"Nature"},{"key":"8_CR21","doi-asserted-by":"crossref","unstructured":"Goff SP, Gilboa E, Witte ON, Baltimore D: Structure of the abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA. Cell 22\u2013777\u2013785, 1980.","DOI":"10.1016\/0092-8674(80)90554-1"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1073\/pnas.80.12.3623","volume":"80","author":"EP Reddy","year":"1983","unstructured":"Reddy EP, Smith MJ, Srinivasan A: Nucleotide sequence of Abelson murine leukemia virus genome: Structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci USA 80:3623\u20133627, 1983.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.bi.52.070183.001505","volume":"52","author":"JM Bishop","year":"1983","unstructured":"Bishop JM: Cellular oncogenes and retroviruses. Ann Rev Biochem 52:301\u2013354, 1983.","journal-title":"Ann Rev Biochem"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0042-6822(84)90409-4","volume":"133","author":"A Schultz","year":"1984","unstructured":"Schultz A, Oroszlan S: Myristylation of gag-one fusion proteins in mammalian transforming retroviruses. Virology 133:431\u2013437, 1984.","journal-title":"Virology"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/JVI.39.3.870-878.1981","volume":"39","author":"ON Witte","year":"1981","unstructured":"Witte ON, Ponticelli A, Gifford A, Baltimore D, Rosenberg N, Elder J: Phosphorylation of the abelson murine leukemia virus transforming protein. J Virol 39:870\u2013878, 1981.","journal-title":"J Virol"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1073\/pnas.78.3.1552","volume":"78","author":"BM Sefton","year":"1981","unstructured":"Sefton BM, Hunter T, Raschke WC: Evidence that the Abelson virus protein function in vivo as a protein kinase that phosphorylates tyrosine. Proc Natl Acad Sci USA 78:1552\u20131556, 1981.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR27","doi-asserted-by":"crossref","unstructured":"Witte ON, Goff S, Rosenberg N, Baltimore D: A transformation-defective mutant of abelson murine leukemia virus lacks protein kinase activity. Proc Natl Acad Sci USA 77:4993\u20134997.","DOI":"10.1073\/pnas.77.8.4993"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/JVI.54.1.114-122.1985","volume":"54","author":"R Prywes","year":"1985","unstructured":"Prywes R, Foulkes JG, Baltimore D: The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. J Virol 54:114\u2013122, 1985.","journal-title":"J Virol"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1073\/pnas.84.22.8021","volume":"84","author":"A Engelman","year":"1987","unstructured":"Engelman A, Rosenberg N: Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis. Proc Natl Acad Sci USA 84:8021\u20138025, 1987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1073\/pnas.84.5.1345","volume":"84","author":"E Kipreos","year":"1987","unstructured":"Kipreos E, Lee GJ, Wang JYJ: Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine. Proc Natl Acad Sci USA 84:1345\u20131349, 1987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/JVI.40.2.472-481.1981","volume":"40","author":"MA Boss","year":"1981","unstructured":"Boss MA, Dreyfuss G, Baltimore D: Localization of the abelson murine leukemia virus protein in a detergent-insoluble subcellular matrix: Architecture of the protein. J Virol 40:472\u2013481, 1981.","journal-title":"J Virol"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/JVI.51.2.547-552.1984","volume":"51","author":"LR Rohrschneider","year":"1984","unstructured":"Rohrschneider LR, Najita LM: Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts. J Virol 51:547\u2013552, 1984.","journal-title":"J Virol"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0092-8674(89)90102-5","volume":"58","author":"RA Etten Van","year":"1989","unstructured":"Van Etten RA, Jackson P, Baltimore D: The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669\u2013678, 1989.","journal-title":"Cell"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/MCB.4.9.1834","volume":"4","author":"FR Cross","year":"1984","unstructured":"Cross FR, Garber EA, Pellman D, Hanafusa H: A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol Cell Biol 4:1834\u20131842, 1984.","journal-title":"Mol Cell Biol"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1128\/MCB.12.4.1864","volume":"12","author":"GQ Daley","year":"1992","unstructured":"Daley GQ, Van Etten RA, Jackson PJ, Bernards A, Baltimore D: Non-myristoylated Abl proteins transform a factor-dependent hematopoietic cell line. Mol Cell Biol 12:1864\u20131871, 1992.","journal-title":"Mol Cell Biol"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(86)90542-8","volume":"45","author":"MP Kamps","year":"1986","unstructured":"Kamps MP, Buss JE, Sefton BM: Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell 45:105\u2013112, 1986.","journal-title":"Cell"},{"key":"8_CR37","first-page":"383","volume":"2","author":"PL Green","year":"1988","unstructured":"Green PL, Kaehler DA, McKearn J, Risser R: Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors. Oncogene 2:383\u2013392, 1988.","journal-title":"Oncogene"},{"key":"8_CR38","unstructured":"Daley GQ, Van Etten RA: Unpublished observations."},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/303825a0","volume":"303","author":"P Besmer","year":"1983","unstructured":"Besmer P, Hardy WD, Zuckerman EE, Bergold P, Lederman L, Snyder HW, Jr.: The Hardy-Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV. Nature 303:825\u2013828, 1983.","journal-title":"Nature"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/JVI.61.4.1193-1202.1987","volume":"61","author":"PJ Bergold","year":"1987","unstructured":"Bergold PJ, Blumenthal JA, D\u2019Andrea E, Snyder HW, Lederman L, Silverstone A, Nguyen H, Besmer P: Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert. J Virol 61:1193\u20131202, 1987.","journal-title":"J Virol"},{"key":"8_CR41","doi-asserted-by":"crossref","unstructured":"Wang JYJ, Ledley F, Goff S, Lee R, Groner Y, Baltimore D: The mouse c-abl locus: Molecular cloning and characterization. Cell 36:349\u2013356.","DOI":"10.1016\/0092-8674(84)90228-9"},{"key":"8_CR42","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1128\/MCB.7.9.3231","volume":"7","author":"A Bernards","year":"1984","unstructured":"Bernards A, Rubin CM, Westbrook CA, Paskind M, Baltimore D: The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol 7:3231\u20133236, 1984.","journal-title":"Mol Cell Biol"},{"key":"8_CR43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/MCB.3.5.773","volume":"3","author":"JYJ Wang","year":"1983","unstructured":"Wang JYJ, Baltimore D: Cellular RNA homologous to the abelson murine leukemia virus transforming gene: Expression and relationship to the viral sequence. Mol Cell Biol 3:773\u2013779, 1983.","journal-title":"Mol Cell Biol"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.84.23.8200","volume":"84","author":"C Oppi","year":"1987","unstructured":"Oppi C, Shore SK, Reddy EP: Nucleotide sequence of testis-derived c-abl cDNAs: Implications for testis-specific transcription and abl oncogene activation. Proc Natl Acad Sci USA 84:8200\u20138204, 1987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(86)90267-9","volume":"44","author":"Y Ben-Neriah","year":"1986","unstructured":"Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D: Alternative 5\u2019 exons in c-abl mRNA. Cell 44:577\u2013586, 1986.","journal-title":"Cell"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0092-8674(86)90450-2","volume":"47","author":"E Shtivelman","year":"1986","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277\u2013284, 1986.","journal-title":"Cell"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3291115","volume":"241","author":"SK Hanks","year":"1988","unstructured":"Hanks SK, Quinn AM, Hunter T: The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241:42\u201352, 1988.","journal-title":"Science"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3787260","volume":"234","author":"GD Kruh","year":"1986","unstructured":"Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, Aaronson SA: A novel human gene closely related to the abl proto-oncogene. Science 234:1545\u20131548, 1986.","journal-title":"Science"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1073\/pnas.87.15.5802","volume":"87","author":"GD Kruh","year":"1990","unstructured":"Kruh GD, Perego R, Miki T, Aaronson SA: The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci USA 87:5802\u20135806, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1128\/MCB.8.2.843","volume":"8","author":"MJ Henkemeyer","year":"1988","unstructured":"Henkemeyer MJ, Bennett RL, Gertler FB, Hoffmann FM: DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster abelson proto-oncogene homolog. Mol Cell Biol 8:843\u2013853, 1988.","journal-title":"Mol Cell Biol"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0092-8674(89)90407-8","volume":"58","author":"FB Gertler","year":"1989","unstructured":"Gertler FB, Bennett RL, Clark MJ, Hoffmann FM: Drosophila abl tyrosine kinase in embryonic CNS axons: A role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58:103\u2013113, 1989.","journal-title":"Cell"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0092-8674(91)90012-N","volume":"65","author":"PL Schwartzberg","year":"1991","unstructured":"Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP: Mice homozygous for the abl ml mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165\u20131176, 1991.","journal-title":"Cell"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0092-8674(91)90011-M","volume":"65","author":"VLJ Tybulewicz","year":"1991","unstructured":"Tybulewicz VLJ, Crawford CE, Jackson PK, Mulligan RC: Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell 65:1153\u20131164, 1991.","journal-title":"Cell"},{"key":"8_CR54","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0021-9258(19)75745-7","volume":"262","author":"DA Towler","year":"1987","unstructured":"Towler DA, Eubanks SR, Towery DS, Adams SP, Glaser L: Amino-terminal processing of proteins by N-myristoylation. J Biol Chem 262:1030\u20131036, 1987.","journal-title":"J Biol Chem"},{"key":"8_CR55","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/j.1460-2075.1989.tb03397.x","volume":"8","author":"P Jackson","year":"1989","unstructured":"Jackson P, Baltimore D: N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 8:449\u2013456, 1989.","journal-title":"EMBO J"},{"key":"8_CR56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(89)90008-1","volume":"59","author":"AS Shaw","year":"1989","unstructured":"Shaw AS, Amrein KE, Hammond C, Stern DF, Sefton BM, Rose JK: The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell 59:627\u2013636, 1989.","journal-title":"Cell"},{"key":"8_CR57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0092-8674(89)90842-8","volume":"58","author":"MD Resh","year":"1989","unstructured":"Resh MD: Specific and saturable binding of pp60v-src to plasma membranes: Evidence for a myristyl-srcreceptor. Cell 58:281\u2013286, 1989.","journal-title":"Cell"},{"key":"8_CR58","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/MCB.6.12.4396","volume":"6","author":"I Sadowski","year":"1986","unstructured":"Sadowski I, Stone JC, Pawson T: A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6:4396\u20134408, 1986.","journal-title":"Mol Cell Biol"},{"key":"8_CR59","first-page":"491","volume":"3","author":"T Pawson","year":"1988","unstructured":"Pawson T: Non-catalytic domains of cytoplasmic protein-tyrosine kinases: Regulatory elements in signal transduction. Oncogene 3:491\u2013495, 1988.","journal-title":"Oncogene"},{"key":"8_CR60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0021-9258(18)89693-4","volume":"260","author":"JYJ Wang","year":"1985","unstructured":"Wang JYJ, Baltimore D: Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. J Biol Chem 260:64\u201371, 1985.","journal-title":"J Biol Chem"},{"key":"8_CR61","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/MCB.9.10.4131","volume":"9","author":"C Koch","year":"1989","unstructured":"Koch C, Moran MF, Sadowski I, Pawson T: The common src homology region 2 domain of cytoplasmic signalling proteins is a positive effector of v-fps tyrosine kinase function. Mol Cell Biol 9:4131\u20134140, 1989.","journal-title":"Mol Cell Biol"},{"key":"8_CR62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JVI.63.2.542-554.1989","volume":"63","author":"JE DeClue","year":"1989","unstructured":"DeClue JE, Martin GS: Linker insertion-deletion mutagenesis of the v-src gene: Isolation of host-and temperature-dependent mutants. J Virol 63:542\u2013554, 1989.","journal-title":"J Virol"},{"key":"8_CR63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1073\/pnas.88.2.627","volume":"88","author":"BJ Mayer","year":"1990","unstructured":"Mayer BJ, Jackson PK, Baltimore D: High-affinity binding of the noncatalytic SH2 segment of the abl tyrosine kinase to tyrosine-phosphorylated cellular proteins. Proc Natl Acad Sci USA 88:627\u2013631, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"8622","DOI":"10.1073\/pnas.87.21.8622","volume":"87","author":"MF Moran","year":"1990","unstructured":"Moran MF, Koch DA, Ellis C, England L, Martin GS, Pawson T: Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA 87:8622\u20138626, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0092-8674(91)90639-G","volume":"64","author":"LC Cantley","year":"1991","unstructured":"Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64:281\u2013302, 1991.","journal-title":"Cell"},{"key":"8_CR66","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1128\/MCB.7.12.4280","volume":"7","author":"AM Pendergast","year":"1987","unstructured":"Pendergast AM, Traugh JA, Witte ON: Normal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation. Mol Cell Biol 7:4280\u20134289, 1987.","journal-title":"Mol Cell Biol"},{"key":"8_CR67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.2183353","volume":"248","author":"ET Kipreos","year":"1990","unstructured":"Kipreos ET, Wang JYJ: Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science 248:217\u2013220, 1990.","journal-title":"Science"},{"key":"8_CR68","unstructured":"Van Etten R, Jackson P, Baltimore D: Unpublished results."},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0092-8674(83)90389-6","volume":"34","author":"R Prywes","year":"1983","unstructured":"Prywes R, Foulkes JG, Rosenberg N, Baltimore D: Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34:569\u2013579, 1983.","journal-title":"Cell"},{"key":"8_CR70","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/JVI.45.3.1028-1036.1983","volume":"45","author":"SM Watanabe","year":"1983","unstructured":"Watanabe SM, Witte ON: Site-directed deletions of Abelson murine leukemia virus define 3\u2032 sequences essential for transformation and lethality. J Virol 45:1028\u20131036, 1983.","journal-title":"J Virol"},{"key":"8_CR71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(81)90389-5","volume":"27","author":"SF Ziegler","year":"1981","unstructured":"Ziegler SF, Whitlock CA, Goff SP, Gifford A, Witte ON: Lethal effect of the abelson murine leukemia virus transforming gene product. Cell 27:477\u2013486, 1981.","journal-title":"Cell"},{"key":"8_CR72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/JVI.41.1.271-285.1982","volume":"41","author":"SP Goff","year":"1982","unstructured":"Goff SP, Tabin CJ, Wang JY-J, Weinberg R, Baltimore D: Transfection of fibroblasts by cloned abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus. J Virol 41:271\u2013285, 1982.","journal-title":"J Virol"},{"key":"8_CR73","unstructured":"Jackson P, Van Etten RA, Baltimore D: Unpublished results."},{"key":"8_CR74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/j.1460-2075.1989.tb03358.x","volume":"8","author":"WM Franz","year":"1989","unstructured":"Franz WM, Berger P, Wang JYJ: Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J 8:137\u2013147, 1989.","journal-title":"EMBO J"},{"key":"8_CR75","unstructured":"Jackson PK, Paskind M, Baltimore D: Activation of transforming ability of c-abl by point mutation in the tyrosine kinase domain. Submitted."},{"key":"8_CR76","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1073\/pnas.87.17.6502","volume":"87","author":"SK Shore","year":"1990","unstructured":"Shore SK, Bogart SL, Reddy EP: Activation of murine c-abl protooncogene: Effect of a point mutation on oncogenic activation. Proc Natl Acad Sci USA 87:6502\u20136506, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR77","unstructured":"Jackson P, Van Etten RA, Daley GQ, Baltimore D: N-terminal mutations can activate c-abl independent of SH3 mutation N-terminal mutations can activate c-abl independent of SH3 mutation. Submitted, 1991."},{"key":"8_CR78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0092-8674(87)90757-4","volume":"49","author":"H Piwinica-worms","year":"1987","unstructured":"Piwinica-worms H, Saunders K, Roberts T, Smith A, Cheng S: Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49:75\u201382, 1987.","journal-title":"Cell"},{"key":"8_CR79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/304167a0","volume":"304","author":"J Groffen","year":"1983","unstructured":"Groffen J, Heisterkamp N, Reynolds FH, Jr., Stephenson JR: Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products. Nature 304:167\u2013169, 1983.","journal-title":"Nature"},{"key":"8_CR80","unstructured":"Jackson P: Unpublished results."},{"key":"8_CR81","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0092-8674(82)90458-5","volume":"29","author":"AS Ponticelli","year":"1982","unstructured":"Ponticelli AS, Whitlock CA, Rosenberg N, Witte ON: In vivo tyrosine phosphorylations of the abelson virus transforming protein are absent in its normal cellular homolog. Cell 29:953\u2013960, 1982.","journal-title":"Cell"},{"key":"8_CR82","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1073\/pnas.88.13.5927","volume":"88","author":"AM Pendergast","year":"1991","unstructured":"Pendergast AM, Muller AJ, Havlik MH, Clark R, McCormick F, Witte ON: Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc Natl Acad Sci USA 88:5927\u20135931, 1991.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR83","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1128\/MCB.5.11.3116","volume":"5","author":"JB Konopka","year":"1985","unstructured":"Konopka JB, Witte ON: Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 5:3116\u20133123, 1985.","journal-title":"Mol Cell Biol"},{"key":"8_CR84","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","volume":"247","author":"TG Lugo","year":"1990","unstructured":"Lugo TG, Pendergast A, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079\u20131082, 1990.","journal-title":"Science"},{"key":"8_CR85","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1128\/MCB.11.3.1553","volume":"11","author":"JR McWhirter","year":"1991","unstructured":"McWhirter JR, Wang JYJ: Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr\/abl fusion proteins. Mol Cell Biol 11:1785\u20131792, 1991.","journal-title":"Mol Cell Biol"},{"key":"8_CR86","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM198010093031511","volume":"303","author":"M Sporn","year":"1980","unstructured":"Sporn M, Todaro G: Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878\u2013880, 1980.","journal-title":"N Engl J Med"},{"key":"8_CR87","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1126\/science.6177040","volume":"216","author":"DR Twardzik","year":"1982","unstructured":"Twardzik DR, Todaro GJ, Marquardt H, Reynolds FH, Jr., Stephenson JR: Transformation induced by abelson murine leukemia virus involves production of a polypeptide growth factor. Science 216:894\u2013897, 1982.","journal-title":"Science"},{"key":"8_CR88","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/j.1460-2075.1986.tb04483.x","volume":"5","author":"A Gebhardt","year":"1986","unstructured":"Gebhardt A, Bell JC, Foulkes JG: Abelson transformed fibroblasts lacking the EGF receptor are not tumourigenic in nude mice. EMBO J 5:2191\u20132195, 1986.","journal-title":"EMBO J"},{"key":"8_CR89","first-page":"191","volume-title":"The Enzymes","author":"T Hunter","year":"1986","unstructured":"Hunter T, Cooper JA: Viral oncogenes and tyrosine phosphorylation. In: The Enzymes. Academic Press, New York, 1986, pp 191\u2013246."},{"key":"8_CR90","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.11.2.1107","volume":"11","author":"L Varticovski","year":"1991","unstructured":"Varticovski L, Daley G, Jackson P, Baltimore D, Cantley L: Activation of PI 3-kinase in cells expressing abl oncogene variants. Mol Cell Biol 11:1107\u20131113, 1991.","journal-title":"Mol Cell Biol"},{"key":"8_CR91","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/MCB.11.4.1804","volume":"11","author":"MF Moran","year":"1991","unstructured":"Moran MF, Polakis P, McCormick F, Pawson T, Ellis C: Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein. Mol Cell Biol 11:1804\u20131812, 1991.","journal-title":"Mol Cell Biol"},{"key":"8_CR92","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.V65.5.1039.1039","volume":"65","author":"RE Champlin","year":"1985","unstructured":"Champlin RE, Golde DW: Chronic myelogenous leukemia: Recent advances. Blood 65:1039\u20131047, 1985.","journal-title":"Blood"},{"key":"8_CR93","first-page":"1197","volume":"132","author":"PC Nowell","year":"1960","unstructured":"Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1197\u20131200, 1960.","journal-title":"Science"},{"key":"8_CR94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290\u2013293, 1973.","journal-title":"Nature"},{"key":"8_CR95","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V22.6.664.664","volume":"22","author":"J Whang","year":"1963","unstructured":"Whang J, Frei III E, Tjio JH, Carbone PP, Brecher G. The distribution of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Blood 22:664\u2013673, 1963.","journal-title":"Blood"},{"key":"8_CR96","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(63)91620-9","volume":"1","author":"IM Tough","year":"1963","unstructured":"Tough IM, Jacobs PA, Court-Brown WM, Baikie AG, Williamson ERD: Cytogenetic studies on bone-marrow in chronic myeloid leukaemia. Lancet 1:844\u2013846, 1963.","journal-title":"Lancet"},{"key":"8_CR97","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.V66.5.1155.1155","volume":"66","author":"M Allouche","year":"1985","unstructured":"Allouche M, Bourinbaiar A, Georgoulias V: T-cell lineage involvement in lymphoid blast crisis of chronic myeloid leukemia. Blood 66:1155\u20131161, 1985.","journal-title":"Blood"},{"key":"8_CR98","doi-asserted-by":"crossref","unstructured":"Kurzrock R, Gutterman J, Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319:990\u2013998.","DOI":"10.1056\/NEJM198810133191506"},{"key":"8_CR99","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.me.40.020189.000553","volume":"40","author":"SS Clark","year":"1988","unstructured":"Clark SS, Crist WM, Witte ON: Molecular pathogenesis of Ph-positive leukemias. Ann Rev Med 40:113\u2013122, 1988.","journal-title":"Ann Rev Med"},{"key":"8_CR100","doi-asserted-by":"crossref","unstructured":"Daley GQ, Ben-Neriah Y: Implicating the bcrlabl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. In: Advances in Cancer Research. Academic Press, San Diego, 1991, pp 151\u2013184.","DOI":"10.1016\/S0065-230X(08)60998-7"},{"key":"8_CR101","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","volume":"300","author":"A Klein de","year":"1982","unstructured":"de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeier A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300:765\u2013767, 1982.","journal-title":"Nature"},{"key":"8_CR102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/306239a0","volume":"306","author":"N Heisterkamp","year":"1983","unstructured":"Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, Grosveld G: Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239\u2013242, 1983.","journal-title":"Nature"},{"key":"8_CR103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93\u201399, 1984.","journal-title":"Cell"},{"key":"8_CR104","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1128\/MCB.7.8.2870","volume":"7","author":"S Collins","year":"1987","unstructured":"Collins S, Coleman H, Groudine M: Expression of bcr and bcr-abl fusion transcripts in normal and leukemic cells. Mol Cell Biol 7:2870\u20132876, 1987.","journal-title":"Mol Cell Biol"},{"key":"8_CR105","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","volume":"37","author":"JB Konopka","year":"1984","unstructured":"Konopka JB, Watanabe SM, Witte ON: An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035\u20131042, 1984.","journal-title":"Cell"},{"key":"8_CR106","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550\u2013554, 1985.","journal-title":"Nature"},{"key":"8_CR107","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y Ben-Neriah","year":"1986","unstructured":"Ben-Neriah Y, Daley GQ, Mes-Masson A-M, Witte ON, Baltimore D: The chronic myelogenous leukemia-specific P210 protein is the product of the bcrlabl hybrid gene. Science 233:212\u2013214, 1986.","journal-title":"Science"},{"key":"8_CR108","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.3541203","volume":"235","author":"SS Clark","year":"1987","unstructured":"Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON: Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science 235:285\u201387, 1987.","journal-title":"Science"},{"key":"8_CR109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0092-8674(87)90007-9","volume":"51","author":"A Hermans","year":"1987","unstructured":"Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33\u201340, 1987.","journal-title":"Cell"},{"key":"8_CR110","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.V70.5.1584.1584","volume":"70","author":"R Kurzrock","year":"1987","unstructured":"Kurzrock R, Shtalrid M, Talpaz M, Kloetzer WS, Gutterman JU: Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. Blood 70:1584\u20131588, 1987.","journal-title":"Blood"},{"key":"8_CR111","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood.V75.5.1146.1146","volume":"75","author":"L Selleri","year":"1990","unstructured":"Selleri L, von Lindern M, Hermans A, Meijer D, Torelli G, Grosveld G: Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood 75:1146\u20131153, 1990.","journal-title":"Blood"},{"key":"8_CR112","first-page":"35","volume":"25","author":"O Dreazen","year":"1988","unstructured":"Dreazen O, Canaani E, Gale RP: Molecular biology of chronic myelogenous leukemia. Semin Hematol 25:35\u201349, 1988.","journal-title":"Semin Hematol"},{"key":"8_CR113","first-page":"261","volume":"2","author":"SJ Chen","year":"1988","unstructured":"Chen SJ, Flandrin G, Daniel MT, Valensi F, Baranger L, Grausz D, Bernheim A, Chen Z, Sigaux F, Berger R: Philadelphia-positive leukemia: Lineage promiscuity and inconsistently rearranged breakpoint cluster region. Leukemia 2:261\u2013273, 1988.","journal-title":"Leukemia"},{"key":"8_CR114","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V71.1.186.186","volume":"71","author":"C Hirsch-Ginsberg","year":"1988","unstructured":"Hirsch-Ginsberg C, Childs C, Chang K-S, Beran M, Cork A, Reuben J, Freireich EJ, Chang LCM, Bollum FJ, Trujillo J, Stass SA: Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood 71:186\u2013195, 1988.","journal-title":"Blood"},{"key":"8_CR115","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/MCB.7.5.1955","volume":"7","author":"K Stam","year":"1987","unstructured":"Stam K, Heisterkamp N, Reynolds FH, Jr., Groffen J: Evidence that the phi gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mol Cell Biol 7:1955\u20131960, 1987.","journal-title":"Mol Cell Biol"},{"key":"8_CR116","first-page":"559","volume":"4","author":"MS Timmons","year":"1989","unstructured":"Timmons MS, Witte ON: Structural characterization of the bcr gene product. Oncogene 4:559\u2013567, 1989.","journal-title":"Oncogene"},{"key":"8_CR117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/j.1460-2075.1987.tb04727.x","volume":"6","author":"IK Hariharan","year":"1987","unstructured":"Hariharan IK, Adams JA: cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia. EMBO J 6:115\u2013119, 1987.","journal-title":"EMBO J"},{"key":"8_CR118","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/351400a0","volume":"351","author":"D Diekmann","year":"1991","unstructured":"Diekmann D, Brill S, Garrett MD, Totty N, Hsuan J, Monfries C, Hall C, Lim L, Hall A: Bcr encodes a GTPase-activating protein for p21racc. Nature 351:400\u2013402, 1991.","journal-title":"Nature"},{"key":"8_CR119","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1128\/MCB.11.4.1785","volume":"11","author":"AJ M\u00dcller","year":"1991","unstructured":"M\u00dcller AJ, Young JC, Pendergast A, Pondel M, Landau NR, Littman DR, Witte ON: BCR first exon sequences specifically activate the BCR\/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive leukemias. Mol Cell Biol 11:1785\u20131792, 1991.","journal-title":"Mol Cell Biol"},{"key":"8_CR120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(91)90148-R","volume":"66","author":"AM Pendergast","year":"1991","unstructured":"Pendergast AM, M\u00dcller AJ, Havlik MH, Maru Y, Witte ON: BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161\u2013171, 1991.","journal-title":"Cell"},{"key":"8_CR121","first-page":"387","volume":"3","author":"IK Hariharan","year":"1988","unstructured":"Hariharan IK, Adams JM, Cory S: bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res 3:387\u2013399, 1988.","journal-title":"Oncogene Res"},{"key":"8_CR122","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","volume":"85","author":"G Daley","year":"1988","unstructured":"Daley G, Baltimore D: Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcrlabl protein. Proc Natl Acad Sci USA 85:9312\u20139316, 1988.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR123","first-page":"275","volume":"6","author":"P Laneuville","year":"1991","unstructured":"Laneuville P, Heisterkamp N, Groffen J: Expression of the chronic myelogenous leukemia-associated p210 bcrlabl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene 6:275\u2013282, 1991.","journal-title":"Oncogene"},{"key":"8_CR124","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.2440107","volume":"237","author":"GQ Daley","year":"1987","unstructured":"Daley GQ, McLaughlin J, Witte ON, Baltimore D: The CML-specific P210 bcrlabl protein, unlike v-abl, does not transform NIH\/3T3 fibroblasts. Science 237:532\u2013535, 1987.","journal-title":"Science"},{"key":"8_CR125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1128\/MCB.9.3.1263","volume":"9","author":"TG Lugo","year":"1989","unstructured":"Lugo TG, Witte ON: The bcr-abl oncogene transforms rat-1 cells and cooperates with v-myc. Mol Cell Biol 9:1263\u20131270, 1989.","journal-title":"Mol Cell Biol"},{"key":"8_CR126","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1073\/pnas.84.18.6558","volume":"84","author":"J McLaughlin","year":"1987","unstructured":"McLaughlin J, Chianese E, Witte ON: In vitro transformation of immature hematopoietic cells by the P210 bcrlabl oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 84:6558\u20136562, 1987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR127","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/MCB.8.10.4079","volume":"8","author":"JC Young","year":"1988","unstructured":"Young JC, Witte ON: Selective transformation of primitive lymphoid cells by the bcrlabl oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol 8:4079\u20134087, 1988.","journal-title":"Mol Cell Biol"},{"key":"8_CR128","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/MCB.9.5.1866","volume":"9","author":"J McLaughlin","year":"1989","unstructured":"McLaughlin J, Chianese E, Witte ON: Alternative forms of the bcrlabl oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 9:1866\u20131874, 1989.","journal-title":"Mol Cell Biol"},{"key":"8_CR129","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1073\/pnas.87.5.1908","volume":"87","author":"PA Scherle","year":"1990","unstructured":"Scherle PA, Dorshkind K, Witte ON: Clonal lymphoid progenitor cell lines expressing the BCR\/ABL oncogene retain full differentiative function. Proc Natl Acad Sci USA 87:1908\u20131912, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/j.1460-2075.1990.tb08187.x","volume":"9","author":"H Rosenbaum","year":"1990","unstructured":"Rosenbaum H, Harris AW, Bath ML, McNeall J, Webb E, Adams JM, Cory S: An E(mu)-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J 9:897\u2013905, 1990.","journal-title":"EMBO J"},{"key":"8_CR131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J: Acute leukemia in bcr\/abl transgenic mice. Nature 344:251\u2013253, 1990.","journal-title":"Nature"},{"key":"8_CR132","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/MCB.9.7.2798","volume":"9","author":"IK Hariharan","year":"1989","unstructured":"Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM: A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9:2798\u20132805, 1989.","journal-title":"Mol Cell Biol"},{"key":"8_CR133","unstructured":"Grosveld G: Personal communication."},{"key":"8_CR134","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/j.1460-2075.1990.tb08212.x","volume":"9","author":"AG Elefanty","year":"1990","unstructured":"Elefanty AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hematopoietic neoplasms in mice. EMBO J 9:1069\u20131078, 1990.","journal-title":"EMBO J"},{"key":"8_CR135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210 bcr\/abl gene of the Philadelphia chromosome. Science 247:824\u2013830, 1990.","journal-title":"Science"},{"key":"8_CR136","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1073\/pnas.88.24.11335","volume":"88","author":"GQ Daley","year":"1991","unstructured":"Daley GQ, Van Etten RA, Baltimore D: Blast crisis in a murine model of chronic myelogenous leukemia. Proc Natl Acad Sci USA 88:11335\u201311338, 1991.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR137","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1073\/pnas.87.17.6649","volume":"87","author":"MA Kelliher","year":"1990","unstructured":"Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and bcr\/abl. Proc Natl Acad Sci USA 87:6649\u20136653, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR138","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.88.15.6506","volume":"88","author":"ML Scott","year":"1991","unstructured":"Scott ML, Van Etten RA, Daley GQ, Baltimore D: v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Proc Natl Acad Sci USA 88:6506\u20136510, 1991.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR139","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.88.4.1585","volume":"88","author":"S-W Chung","year":"1991","unstructured":"Chung S-W, Wong PMC, Durkin H, Wu Y-S, Petersen J: Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene. Proc Natl Acad Sci USA 88:1585\u20131589, 1991.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR140","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1128\/MCB.11.9.4710","volume":"11","author":"M Kelliher","year":"1991","unstructured":"Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N: Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR\/ABL oncogene. Mol Cell Biol 11:4710\u20134716, 1991.","journal-title":"Mol Cell Biol"},{"key":"8_CR141","unstructured":"Van Etten RA, Daley GQ, in preparation."}],"container-title":["Cancer Treatment and Research","Oncogenes and Tumor Suppressor Genes in Human Malignancies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-3088-6_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T04:34:40Z","timestamp":1639283680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-3088-6_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9781461363491","9781461530886"],"references-count":141,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-3088-6_8","relation":{},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[1993]]}}}